Efficacy and safety of erenumab in women with a history of menstrual migraine

Efficacy and safety of erenumab in women with a history of menstrual migraine

Abstract Background We performed a post hoc, subgroup analysis of a phase 3, randomized, double-blind, placebo-controlled study of erenumab for prevention of episodic migraine (STRIVE) to determine the efficacy and safety of erenumab in women with self-reported menstrual migraine. Methods Patients r...

Full description

Bibliographic Details
Main Authors: Jelena M. Pavlovic, Koen Paemeleire, Hartmut Göbel, Jo Bonner, Alan Rapoport, Risa Kagan, Feng Zhang, Hernan Picard, Daniel D. Mikol
Format: Article
Language:English
Published: BMC 2020-08-01
Series:The Journal of Headache and Pain
Subjects:
Erenumab
Headache
Episodic migraine
Migraine prevention
Pure menstrual migraine
Menstrually related migraine
Online Access:http://link.springer.com/article/10.1186/s10194-020-01167-6

Internet

http://link.springer.com/article/10.1186/s10194-020-01167-6

Similar Items